SCHEMBL6708577

SCHEMBL6708577

Cn1c(C(=O)Nc2ccc(Cl)cc2-c2noc(=O)[nH]2)cc2cccc(NC(=O)c3cccc(S(=O)(=O)N4CCOCC4)c3)c21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 3/20 0.54
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 2/20 0.47
ATM Q13315 1/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 2/20 0.45
POLB P06746 1/20 0.45
KDM4E B2RXH2 1/20 0.45
KDM1A O60341 2/20 0.44
BRD4 O60885 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
BRD2 P25440 1/20 0.44
CYP2C19 P33261 1/20 0.44
PLK4 O00444 1/20 0.44
ROCK2 O75116 1/20 0.44
MAP4K4 O95819 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711698 0.92 ALB (0.52) ALBMEN1KMT2AALDH1A1LMNA
SCHEMBL6709196 0.90 THRB (0.46) ALBMEN1KMT2AALDH1A1LMNA
SCHEMBL6709926 0.87 ALB (0.55) ALBMEN1KMT2AALDH1A1ATM
SCHEMBL6710108 0.86 ALB (0.56) ALBMEN1KMT2AALDH1A1ATM
SCHEMBL6710168 0.85 ALDH1A1 (0.39) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL6707647 0.81 GRM4 (0.46) MEN1KMT2ALMNAROCK1
SCHEMBL6707643 0.81 ALB (0.64) ALBMEN1KMT2AALDH1A1LMNA
SCHEMBL6708841 0.79 GRIK1 (0.40) ROCK1
SCHEMBL6711760 0.79 ALB (0.53) ALBMEN1KMT2AALDH1A1LMNA
SCHEMBL6711825 0.79 GRIK1 (0.41) POLBROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALB 1298/4885MEN1 4100/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.